Dabur Research Foundation
Dabur Research Foundation (DRF) is an Indian contract research organization offering pre-clinical services in drug discovery and development. It was established in 1979 to spearhead the research and development activities of Dabur, India's largest Ayurvedic medicine manufacturer.
 | |
| Founded | 1979 |
|---|---|
| Headquarters | Sahibabad, Ghaziabad - 201010 (UP) , |
| Parent | Dabur India Limited |
| Website | daburresearch.in |
References
- Articles about International Finance Corporation - Economic Times
- BioSpectrumIndia - the business of biotech - Customer relationships in a competitive market
- Elephant Capital buys stake in ClinTec Intl for Rs 58 cr
- Cosmetics testing kills 3.9 million animals - BioSpectrum Asia
- Burmans plan Rs 925-crore healthcare fund
- Dabur to re-expand its pharma research
Further reading
- Madaan, Alka; Singh, Pratibha; Awasthi, Anshumali; Verma, Ritu; Singh, Anu T.; Jaggi, Manu; Mishra, Shiva Kant; Kulkarni, Sadanand; Kulkarni, Hrishikesh (2012). "Efficiency and mechanism of intracellular paclitaxel delivery by novel nanopolymer-based tumor-targeted delivery system, Nanoxel". Clinical and Translational Oncology. 15 (1): 26–32. doi:10.1007/s12094-012-0883-2. PMID 22855169.
- Kumar, Vivek; Madaan, Alka; Sanna, Vinod K.; Vishnoi, Manupriya; Joshi, Narendra; Singh, Anu T.; Jaggi, Manu; Sharma, Pramod K.; et al. (2009). "Anticancer and immunomodulatory activities of novel 1,8-naphthyridine derivatives". Journal of Enzyme Inhibition and Medicinal Chemistry. 24 (5): 1169–78. doi:10.1080/14756360802696802. PMID 19555167.
- Bansal, Tripta; Jaggi, Manu; Khar, Roop K; Talegaonkar, Sushama (2009). "Emerging Significance of Flavonoids as P-Glycoprotein Inhibitors in Cancer Chemotherapy". Journal of Pharmacy & Pharmaceutical Sciences. 12 (1): 46–78. CiteSeerX 10.1.1.557.474. PMID 19470292.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.